← Browse by Condition
Medical Condition

cardiac surgery

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for cardiac surgery sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — cardiac surgery Clinical Trials

How many clinical trials are currently recruiting for cardiac surgery?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for cardiac surgery, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cardiac surgery?
cardiac surgery research spans Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cardiac surgery clinical trial?
Eligibility criteria for cardiac surgery trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 3
1
Top Sponsors
University Health Network, Toronto 1 trial
IPERF SAS 1 trial
Centre Hospitalier Universitaire, Amiens 1 trial
Ziekenhuis Oost-Limburg 1 trial

Recruiting Clinical Trials

NCT06287619 Phase 2
Recruiting
Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac Surgery
Enrollment
60 pts
Location
Canada
Sponsor
University Health Network, Tor...
View Trial →
NCT07163234
Recruiting
Safety of the IPERF Femoral Arterial Cannula in Patients Undergoing Planned Cardiac Surgery With Extracorporeal Circulation Via Femoral Approach
Enrollment
15 pts
Location
France
Sponsor
IPERF SAS
View Trial →
NCT06381063 Phase 3
Recruiting
Non-steroidal Anti-inflammatory in Cardiac Surgery
Enrollment
238 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
View Trial →
NCT07200726
Recruiting
The Role of Neuroinflammation on Neurocognitive Outcome in Cardiac Surgery
Enrollment
80 pts
Location
Belgium
Sponsor
Ziekenhuis Oost-Limburg
View Trial →

Related Conditions

chronic iron deficiency anaemia (1) ischemia limb (1) acute postoperative pain (1) non steroidal anti inflammatory drugs (1) pain intensity (1) multimodal pain management (1) postoperative neurocognitive dysfunction (1) postoperative neurocognitive disorder (1) major surgery under general anesthesia (1) major surgery in adult patients (1) postoperative fatigue (1) elderly patients (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology